Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Gain-of-Function Mutation in the α9 Nicotinic Acetylcholine Receptor Alters Medial Olivocochlear Efferent Short-Term Synaptic Plasticity.
Wedemeyer C, Vattino LG, Moglie MJ, Ballestero J, Maison SF, Di Guilmi MN, Taranda J, Liberman MC, Fuchs PA, Katz E, Elgoyhen AB. Wedemeyer C, et al. Among authors: katz e. J Neurosci. 2018 Apr 18;38(16):3939-3954. doi: 10.1523/JNEUROSCI.2528-17.2018. Epub 2018 Mar 23. J Neurosci. 2018. PMID: 29572431 Free PMC article.
Electrical properties and functional expression of ionic channels in cochlear inner hair cells of mice lacking the alpha10 nicotinic cholinergic receptor subunit.
Gómez-Casati ME, Wedemeyer C, Taranda J, Lipovsek M, Dalamon V, Elgoyhen AB, Katz E. Gómez-Casati ME, et al. Among authors: katz e. J Assoc Res Otolaryngol. 2009 Jun;10(2):221-32. doi: 10.1007/s10162-009-0164-0. Epub 2009 Feb 28. J Assoc Res Otolaryngol. 2009. PMID: 19252947 Free PMC article.
Constitutive expression of the alpha10 nicotinic acetylcholine receptor subunit fails to maintain cholinergic responses in inner hair cells after the onset of hearing.
Taranda J, Ballestero JA, Hiel H, de Souza FS, Wedemeyer C, Gómez-Casati ME, Lipovsek M, Vetter DE, Fuchs PA, Katz E, Elgoyhen AB. Taranda J, et al. Among authors: katz e. J Assoc Res Otolaryngol. 2009 Sep;10(3):397-406. doi: 10.1007/s10162-009-0173-z. Epub 2009 May 19. J Assoc Res Otolaryngol. 2009. PMID: 19452222 Free PMC article.
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
Cree BAC, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, She D, Rees W, Smith M, Cimbora D, Katz E, Bennett JL; N-MOmentum study investigators. Cree BAC, et al. Among authors: katz e. Lancet Neurol. 2024 Jun;23(6):588-602. doi: 10.1016/S1474-4422(24)00077-2. Lancet Neurol. 2024. PMID: 38760098 Clinical Trial.
1,357 results